Chinese expert consensus on prevention and treatment of immunotherapeutic and molecular targeted agents-related infections in patients with hematological malignancies (2021 version).
10.3760/cma.j.issn.0253-2727.2021.09.002
- Collective Name:Infectiology Group, Chinese Society of Hematology, Chinese Medical Association;Lymphocytic Disease Group, Chinese Society of Hematology, Chinese Medical Association;Anti-lymphoma Alliance, Chinese Society of Clinical Oncology (CSCO)
- Publication Type:Journal Article
- MeSH:
China;
Consensus;
Hematologic Neoplasms/drug therapy*;
Humans;
Immunotherapy;
Molecular Targeted Therapy
- From:
Chinese Journal of Hematology
2021;42(9):717-727
- CountryChina
- Language:Chinese
